Perspective Therapeutics (CATX) Institutional Ownership → Elon’s New A.I. Device is About to Shock the World (From InvestorPlace) (Ad) Free CATX Stock Alerts 1.66 +0.02 (+0.91%) (As of 12:39 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort Interest Institutional Ownership Changes (13F Filings) for Perspective Therapeutics (NYSEAMERICAN:CATX)CurrentInstitutional OwnershipPercentage54.66%Number ofInstitutional Buyers(last 12 months)7Number ofInstitutional Sellers(last 12 months)1 Get CATX Insider Trade Alerts Want to know when executives and insiders are buying or selling Perspective Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CATX Institutional Buying and Selling by Quarter Ad InvestorPlaceElon’s New A.I. Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. Perspective Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/26/2024 ZWJ Investment Counsel Inc.22,000$26K0.0%N/A0.004% 4/24/2024 Simplicity Wealth LLC33,570$40K0.0%N/A0.006% 1/22/2024Perkins Capital Management Inc.700,000$281K0.2%-73.8%0.249% 1/11/2024 Taylor & Morgan Wealth Management LLC625,000$251K0.2%+8.7%0.223% 11/8/2023HighTower Advisors LLC1,147,038$314K0.0%N/A0.409% 11/2/2023Perkins Capital Management Inc.2,671,644$731K0.7%N/A0.952% 10/24/2023 Bank of New York Mellon Corp154,238$42K0.0%N/A0.055% 10/16/2023 Wealth Effects LLC110,000$30K0.0%N/A0.039% 10/5/2023 Taylor & Morgan Wealth Management LLC575,000$157K0.1%N/A0.205% (Data available from 1/1/2016 forward) CATX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CATX shares? During the previous two years, the following institutional investors and hedge funds held shares of Perspective Therapeutics shares: HighTower Advisors LLC ($314K), Perkins Capital Management Inc. ($281K), Taylor & Morgan Wealth Management LLC ($251K), Bank of New York Mellon Corp ($42K), Simplicity Wealth LLC ($40K), and Wealth Effects LLC ($30K), and ZWJ Investment Counsel Inc. ($26K).Learn more on CATX's institutional investors. What percentage of Perspective Therapeutics stock is owned by institutional investors? 54.66% of Perspective Therapeutics stock is owned by institutional investors. Learn more on CATX's institutional investor holdings. Which institutional investors have been buying Perspective Therapeutics stock? The following institutional investors have purchased Perspective Therapeutics stock in the last 24 months: Perkins Capital Management Inc. ($2.67M), HighTower Advisors LLC ($1.15M), Taylor & Morgan Wealth Management LLC ($625K), Bank of New York Mellon Corp ($154.24K), Wealth Effects LLC ($110K), Simplicity Wealth LLC ($33.57K), and ZWJ Investment Counsel Inc. ($22K). How much institutional buying is happening at Perspective Therapeutics? Institutional investors have bought a total of 4,763,490 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions. Which Perspective Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Perspective Therapeutics stock in the last 24 months: Perkins Capital Management Inc. ($1.97M). How much institutional selling is happening at Perspective Therapeutics? Institutional investors have sold a total of 1,971,644 shares in the last 24 months. This volume of shares sold represents approximately $0.00 in transactions. Related Companies: MDXG Institutional Ownership AORT Institutional Ownership ATRC Institutional Ownership FNA Institutional Ownership SILK Institutional Ownership ATRI Institutional Ownership KIDS Institutional Ownership TMCI Institutional Ownership EMBC Institutional Ownership SIBN Institutional Ownership This page (NYSEAMERICAN:CATX) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaNvidia CEO Says It Will Be “the Next Revolution” Beyond AIBanyan Hill PublishingHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Perspective Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
